B A C Cree

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
    B A C Cree
    Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, 350 Parnassus Ave, Suite 908, San Francisco, CA 94117, USA
    Neurology 63:2039-45. 2004
  2. ncbi request reprint An open label study of the effects of rituximab in neuromyelitis optica
    B A C Cree
    Multiple Sclerosis Center, University of California, San Francisco 94117, USA
    Neurology 64:1270-2. 2005
  3. ncbi request reprint Emerging monoclonal antibody therapies for multiple sclerosis
    Bruce Cree
    Multiple Sclerosis Center at UCSF, San Francisco, California 94117, USA
    Neurologist 12:171-8. 2006
  4. ncbi request reprint Response to interferon beta-1a treatment in African American multiple sclerosis patients
    Bruce A C Cree
    Multiple Sclerosis Center, University of California, San Francisco, 94117, USA
    Arch Neurol 62:1681-3. 2005
  5. ncbi request reprint Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis
    Lisa F Barcellos
    Department of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA 94143 0435, USA
    Ann Neurol 55:793-800. 2004
  6. pmc Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome
    D T Okuda
    Department of Neurology, UCSF Multiple Sclerosis Center, University of California, San Francisco, San Francisco, USA
    Neurology 76:686-92. 2011
  7. ncbi request reprint Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis
    Stacy J Caillier
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    J Immunol 181:5473-80. 2008
  8. doi request reprint Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
    Sergio E Baranzini
    Department of Neurology, University of California, San Francisco, CA 94143 0435, USA
    Hum Mol Genet 18:767-78. 2009
  9. pmc Vitamin D in African Americans with multiple sclerosis
    J M Gelfand
    Department of Neurology, UCSF Multiple Sclerosis Center, San Francisco, CA, USA
    Neurology 76:1824-30. 2011
  10. pmc Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
    Jorge R Oksenberg
    Department of Neurology, University of California at San Francisco, San Francisco, CA 94143 0435, USA
    Am J Hum Genet 74:160-7. 2004

Detail Information

Publications22

  1. ncbi request reprint Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
    B A C Cree
    Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, 350 Parnassus Ave, Suite 908, San Francisco, CA 94117, USA
    Neurology 63:2039-45. 2004
    ..African American (AA) individuals are thought to develop multiple sclerosis (MS) less frequently than Caucasian American (CA) individuals...
  2. ncbi request reprint An open label study of the effects of rituximab in neuromyelitis optica
    B A C Cree
    Multiple Sclerosis Center, University of California, San Francisco 94117, USA
    Neurology 64:1270-2. 2005
    ..Seven of eight patients experienced substantial recovery of neurologic function over 1 year of average follow-up. The pretreatment median Expanded Disability Status Scale score was 7.5, and at follow-up examination was 5.5 (p = 0.013)...
  3. ncbi request reprint Emerging monoclonal antibody therapies for multiple sclerosis
    Bruce Cree
    Multiple Sclerosis Center at UCSF, San Francisco, California 94117, USA
    Neurologist 12:171-8. 2006
    ..Because of their accessibility, proteins expressed on the surface of immune system cell lineages are appealing targets for monoclonal antibody therapies...
  4. ncbi request reprint Response to interferon beta-1a treatment in African American multiple sclerosis patients
    Bruce A C Cree
    Multiple Sclerosis Center, University of California, San Francisco, 94117, USA
    Arch Neurol 62:1681-3. 2005
    ..To our knowledge, it is not known to what extent treatment with interferon beta-1a will effect the MS disease course within the AA population...
  5. ncbi request reprint Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis
    Lisa F Barcellos
    Department of Neurology, School of Medicine, University of California at San Francisco, San Francisco, CA 94143 0435, USA
    Ann Neurol 55:793-800. 2004
    ..Our results provide strong evidence for linkage and association to a new candidate disease gene on chromosome 17q11 in MS and suggest that variation within NOS2A or a nearby locus contributes to disease susceptibility...
  6. pmc Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome
    D T Okuda
    Department of Neurology, UCSF Multiple Sclerosis Center, University of California, San Francisco, San Francisco, USA
    Neurology 76:686-92. 2011
    ....
  7. ncbi request reprint Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis
    Stacy J Caillier
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    J Immunol 181:5473-80. 2008
    ..The data underscore the power of the African American MS dataset to identify disease genes by association in a region of high linkage disequilibrium...
  8. doi request reprint Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis
    Sergio E Baranzini
    Department of Neurology, University of California, San Francisco, CA 94143 0435, USA
    Hum Mol Genet 18:767-78. 2009
    ..Gene ontology-based analysis shows a functional dichotomy between genes involved in the susceptibility pathway and those affecting the clinical phenotype...
  9. pmc Vitamin D in African Americans with multiple sclerosis
    J M Gelfand
    Department of Neurology, UCSF Multiple Sclerosis Center, San Francisco, CA, USA
    Neurology 76:1824-30. 2011
    ..To evaluate whether vitamin D is associated with multiple sclerosis (MS) status and disease severity in African Americans...
  10. pmc Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans
    Jorge R Oksenberg
    Department of Neurology, University of California at San Francisco, San Francisco, CA 94143 0435, USA
    Am J Hum Genet 74:160-7. 2004
    ..This finding is unlikely to be solely explained by admixture, since a substantial proportion of the susceptibility chromosomes from African American patients with MS displayed haplotypes consistent with an African origin...
  11. doi request reprint Natalizumab dosage suspension: are we helping or hurting?
    Timothy W West
    Multiple Sclerosis Center, University of California at San Francisco, San Francisco, CA, USA
    Ann Neurol 68:395-9. 2010
    ..Some of these flares can be clinically severe, with a high number of contrast-enhanced lesions, suggesting a possible rebound of disease activity...
  12. doi request reprint Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis
    Bruce A C Cree
    Multiple Sclerosis Center at University of California, San Francisco, 94117, USA
    Ann Neurol 68:145-50. 2010
    ..To evaluate the efficacy of 4.5mg nightly naltrexone on the quality of life of multiple sclerosis (MS) patients...
  13. doi request reprint Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA
    Bruce A C Cree
    Department of Neurology, University of California San Francisco, USA
    Arch Neurol 66:226-33. 2009
    ....
  14. pmc A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01
    Bruce A C Cree
    Department of Neurology, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 5:e11296. 2010
    ..Whether other major histocompatibility complex (MHC) genes contribute to MS susceptibility is controversial...
  15. pmc Refining the association of MHC with multiple sclerosis in African Americans
    Joseph P McElroy
    Department of Neurology, University of California, San Francisco, CA 94143, USA
    Hum Mol Genet 19:3080-8. 2010
    ....
  16. pmc Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures
    D T Okuda
    UCSF Multiple Sclerosis Center, University of California, San Francisco, San Francisco, California 94117, USA
    Brain 132:250-9. 2009
    ....
  17. doi request reprint Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis
    A J Green
    Multiple Sclerosis Center, Department of Neurology, University of California San Francisco, San Francisco, California, USA
    J Neurol Neurosurg Psychiatry 80:1002-5. 2009
    ....
  18. ncbi request reprint Neuromyelitis optica
    Bruce A C Cree
    Department of Neurology, University of California San Francisco, USA
    Semin Neurol 22:105-22. 2002
    ..The history of NMO, its nosology, associations with other diseases, and current concepts of its pathogenesis and treatment is reviewed in this article...
  19. ncbi request reprint Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions
    E M Frohman
    Department of Neurology, University of Texas Southwestern Medical Center at Dallas, 75235, USA
    Arch Neurol 62:1345-56. 2005
    ....
  20. ncbi request reprint A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility
    David Reich
    Department of Genetics, Harvard Medical School, Boston, Massachusetts, USA
    Nat Genet 37:1113-8. 2005
    ..We describe here the first high-powered admixture scan, focusing on 605 African American cases and 1,043 African American controls, and report a locus on chromosome 1 that is significantly associated with multiple sclerosis...
  21. ncbi request reprint Acute transverse myelitis: is the "idiopathic" form vanishing?
    Bruce A C Cree
    Neurology 65:1857-8. 2005
  22. ncbi request reprint Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations
    Elliot M Frohman
    Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    Arch Neurol 62:1519-30. 2005
    ....